Skip to main
  1. Stocks
  2. Medical Properties Trust Inc
  3. Forecast
MPT

MPT Stock Forecast & Price Target

MPT Analyst Ratings

Based on 2 analyst ratings
Sell
Strong Buy 0%
Buy 0%
Hold 0%
Sell 100%
Strong Sell 0%

Bulls say

Medical Properties Trust is supported by a portfolio of net-leased healthcare facilities whose long-term leases shift property-level costs to tenants, giving cash flows leverage to any improvement in hospital operating conditions. The bullish case also rests on meaningful embedded value recovery, with former Steward assets, former Prospect assets, and Priory assets cited as potential sources of ~$2.3 billion, ~$550 million, and ~$180 million of value recovery, respectively, while tenant issues at HSA, NOR, and Priory could lift cash rent collections. In addition, management’s plan to monetize non-income-producing assets and refinance the $2.4 billion of secured debt against 2026 and 2027 maturities could improve balance sheet flexibility and support AFFO, which is estimated at ~$0.58/share in the stronger scenario.

Bears say

Medical Properties Trust is facing a strained fundamental setup because tenant distress at Steward, Prospect, HSA, and the Priory restructuring keeps rent collections uncertain and delays any reliable earnings recovery. Its leverage has also risen after issuing $2.4 billion of secured debt at 9.25% to retire roughly $2.5 billion of bonds yielding 3.7%, while continued development spending, capex, and working capital loans add cash demands with uncertain near-term returns. With about $216 million of cash net of LOC balance against $94 million of committed developments and an estimated cash burn of $160 million in 2027 and 2028, the tight liquidity profile and upcoming maturities leave little margin for error.

MPT has been analyzed by 2 analysts, with a consensus rating of Sell. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 100% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medical Properties Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

MPT Analyst Forecast & Price Prediction

Get the latest MPT stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MPT

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medical Properties Trust Inc (MPT) Forecast

Analysts have given MPT a Sell based on their latest research and market trends.

According to 2 analysts, MPT has a Sell consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.90, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.90, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medical Properties Trust Inc (MPT)


MPT Analyst Forecast & Price Prediction

Get the latest MPT stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MPT

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MPT stock data and trends